qingfeng zhu
Johns Hopkins University
H-index: 25
North America-United States
Top articles of qingfeng zhu
Identification of a novel morphology of tertiary lymphoid structure in patients with hepatocellular carcinoma treated with neoadjuvant immune checkpoint blockade
Cancer Research
2024/3/22
Jae W Lee
H-Index: 3
Sarah Mitchell
H-Index: 17
Qingfeng Zhu
H-Index: 15
Hao Wang
H-Index: 29
Mark Yarchoan
H-Index: 27
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial
Nature Cancer
2024/2/14
Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cells
Science Advances
2024/2/7
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma
Clinical Cancer Research
2024/4/2
Machine learning integrating spatial omics uncovers humoral immunity patterns in intratumoral tertiary lymphoid structures in pancreatic cancer pathologic responders
Cancer Research
2024/3/22
Integrating spatial multi-omics data with spatial quantitative pharmacology (spQSP) model to simulate human neoadjuvant immunotherapy clinical trial of hepatocellular carcinoma
Cancer Research
2024/3/22
704 Biological activity of FLX475, an oral CCR4 antagonist, as monotherapy and in combination with pembrolizumab in advanced cancer
2023/11/1
Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade
bioRxiv
2023/10/26
Jae W Lee
H-Index: 3
Sarah Mitchell
H-Index: 17
Qingfeng Zhu
H-Index: 15
Hao Wang
H-Index: 29
Mark Yarchoan
H-Index: 27
Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence
Genome medicine
2023/9/18
Shuming Zhang
H-Index: 1
Long Yuan
H-Index: 8
Qingfeng Zhu
H-Index: 15
Atul Deshpande
H-Index: 5
Mark Yarchoan
H-Index: 27
Informing virtual clinical trials of hepatocellular carcinoma with spatial multi-omics analysis of a human neoadjuvant immunotherapy clinical trial
bioRxiv
2023/8/15
A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable …
Nature communications
2023/6/20
Large-scale transcriptomic profiling of the tumor immune microenvironment in ALK+ lung cancer.
2023/6/1
Vincent K Lam
H-Index: 10
Qingfeng Zhu
H-Index: 15
Andrew Elliott
H-Index: 12
Valsamo Anagnostou
H-Index: 31
Clinical and biological activity of FLX475, an oral CCR4 antagonist, in advanced cancer.
2023/6/1
Spatially resolved immune receptor repertoires from Visium transcriptomic libraries
The Journal of Immunology
2023/5/1
Qingfeng Zhu
H-Index: 15
Lei Zheng
H-Index: 11
Uncovering the spatial landscape of molecular interactions within the tumor microenvironment through latent spaces
Cell systems
2023/4/19
Single-cell RNA and TCR sequencing of tumor infiltrating lymphocytes identifies changes in pancreatic ductal adenocarcinomas following neoadjuvant treatment with combined anti …
Cancer Research
2023/4/4
Tumor-and Nerve-Derived Axon Guidance Molecule Promotes Pancreatic Ductal Adenocarcinoma Progression and Metastasis through Macrophage Reprogramming
bioRxiv
2023
Keyu Li
H-Index: 7
Qingfeng Zhu
H-Index: 15
Elizabeth Thompson
H-Index: 17
Alex Kolodkin
H-Index: 37
Lei Zheng
H-Index: 11
711 Interim results of a phase 2 study of nivolumab and relatlimab in advanced mismatch repair deficient (dMMR) cancers resistant to prior PD-(L) 1 inhibition
J Immunother
2022
Chemoradiation-induced alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer
Oncotarget
2022
Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy
Cancer Cell
2022/11/14
